Sampling intrinsic AV conduction time
US-9220905-B2 · Dec 29, 2015 · US
US9597512B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9597512-B2 |
| Application number | US-201113084244-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 11, 2011 |
| Priority date | Mar 13, 2008 |
| Publication date | Mar 21, 2017 |
| Grant date | Mar 21, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods for optimizing an atrioventricular (AV) pacing delay interval based upon ECG-based optimization such that an AV pacing delay interval value can be dynamically adjusted in an ambulatory subject. Ends of P-waves are determined. An operating atrioventricular interval is modified to maintain intervals between the determined ends of P-waves and beginnings of corresponding following QRS complexes above a predetermined certain value. The value may be between 30 and 60 milliseconds.
Opening claim text (preview).
The invention claimed is: 1. A method of adjusting an operating atrio-ventricular (AV) interval in a pacing therapy delivery device, wherein the operating atrio-ventricular interval extends between delivery of an atrial pacing pulse and delivery of a following ventricular pacing pulse, comprising: monitoring a cardiac activity signal; detecting P-waves within the cardiac activity signal; determining ends of the P-waves within the detected cardiac signal; defining a minimum duration between the ends of the P-waves and beginnings of corresponding QRS complexes as a predetermined certain value; and modifying the operating atrio-ventricular interval to maintain intervals between ends of P-waves and beginnings of corresponding QRS complexes above the predetermined certain value. 2. The method of claim 1 further comprising storing the modified atrio-ventricular interval. 3. The method of claim 2 wherein determining the end of the P-wave comprises measuring one of a slope of the P-wave, a threshold crossing of the P-wave, and a change in a polarity of the cardiac signal. 4. The method of claim 1 wherein the predetermined-certain value is 40 ms. 5. The method of claim 1 wherein the step of modifying includes increasing the operating atrio-ventricular interval. 6. The method of claim 1 further comprising operating the pacing delivery device in a bi-ventricular pacing mode at the operating atrio-ventricular interval. 7. The method of claim 1 further comprising: measuring a duration of a previously detected P-wave; measuring a duration of the P-wave; comparing the duration of the P-wave to a measured duration of a previously detected P-wave; and determining a cardiac status based on a result of the comparison. 8. The method of claim 1 further comprising: measuring a duration of a previously detected QRS complex; measuring a duration of the QRS complex; comparing the duration of the QRS complex to a measured duration of a previously detected QRS complex; and determining a cardiac status based on a result of the comparison. 9. The method of claim 1 further comprising: measuring a heart rate; and adjusting the operating atrio-ventricular interval if there is an increase in the monitored heart rate. 10. The method of claim 9 wherein adjusting the operating atrio-ventricular interval comprises modifying the operating atrio-ventricular interval by one ms for every one beat change in the measured heart rate. 11. The method of claim 1 wherein the predetermined certain value is 30-60 ms. 12. A method of claim 1 wherein determining ends of the P-waves within the detected cardiac signal comprises determining the ends of P-waves within one or more cardiac cycles and wherein modifying the operating atrio-ventricular interval comprises modifying the operating atrio-ventricular interval in cardiac cycles following the one or more cardiac cycle in which the ends of the P-waves were determined. 13. The method of claim 12 further comprising storing the modified atrio-ventricular interval. 14. The method of claim 13 wherein determining the end of the P-wave comprises measuring one of a slope of the P-wave, a threshold crossing of the P-wave, and a change in a polarity of the cardiac signal. 15. The method of claim 12 wherein the predetermined-certain value is 40 ms. 16. The method of claim 12 wherein the step of modifying includes increasing the operating atrio-ventricular interval. 17. The method of claim 12 further comprising operating the pacing delivery device in a bi-ventricular pacing mode at the operating atrio-ventricular interval. 18. The method of claim 12 further comprising: measuring a heart rate; and adjusting the operating atrio-ventricular interval if there is an increase in the monitored heart rate. 19. The method of claim 12 wherein the predetermined certain value is 30-60 ms.
for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy · CPC title
Details of casing-lead connections · CPC title
with a variable atrioventricular delay · CPC title
Casings with electrodes thereon, e.g. leadless stimulators · CPC title
for stimulating the heart at multiple sites of the ventricle or the atrium · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.